{"symbol": "NITE", "companyName": "Nightstar Therapeutics plc", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.nightstartx.com", "description": "Nightstar Therapeutics Ltd is a clinical-stage gene therapy company. It is focused on developing and commercializing a pipeline of novel and potentially curative, one-time retinal gene therapies for patients suffering from rare inherited retinal diseases.", "CEO": "David Fellows", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}